Intervention

Cisplatin/Carboplatin

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions7

Lead sponsors shown4

Clinical trials

4 shown

Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural MesotheliomaNCT06318286 · 2024-03-13

ACTIVE_NOT_RECRUITING

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C MutationNCT05609578 · 2022-11-22

ACTIVE_NOT_RECRUITING

IBI188 Combination Therapy in Solid TumorsNCT04861948 · 2021-05-25

A Phase II Study of Triple-negative Breast Cancer Brain Metastases.NCT04303988 · 2020-03-30

Common conditions

Advanced NSCLC1 Breast Cancer1 Lung Adenocarcinoma1 Malignant Pleural Mesothelioma1 Metastatic Lung Cancer1 Osteosarcoma1 Solid Tumors1

Leading sponsors

Fudan University1 Hyogo Medical University1 Innovent Biologics (Suzhou) Co. Ltd.1 Mirati Therapeutics Inc.1

Trial status mix

ACTIVE_NOT_RECRUITING2

TERMINATED1

UNKNOWN1

Phase mix

PHASE23

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.